CRD-B

Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Total revenue 323.34 M334.6 M332.81 M320.09 M320.13 M 1.31 B Gross profit 90.14 M98.27 M93.79 M84.88 M88.11 M 365.06 M Operating expenses 311.73 M318.52 M312.2 M324.14 M310.8 M 1.27 B Selling/general/admin expenses 74.59 M78.34 M69.39 M71.85 M76.14 M 295.72 M Research & development ————— — Operating income 14.99 M19.47 M24.41 M11.34 M11.98 M 67.2 M Non-Operating Income, Total -3.95 M-4.03 M-4.02 M-4 M-3.31 M -15.36 M Interest expense, net of interest capitalized 3.94 M3.86 M3.79 M3.1 M2.65 M 13.39 M Non-Operating Income, excl. Interest Expenses -5.5 M-5.47 M-5.4 M-4.66 M-3.92 M -19.46 M Unusual income/expense -2.39 M-2.41 M-2.41 M-2.43 M-2.04 M -9.29 M Pretax income 9.22 M13.66 M18.2 M-6.49 M7.29 M 32.67 M Equity in earnings ————— — Taxes 2.48 M5.84 M5.81 M786 K2.38 M 14.82 M Non-controlling/minority interest 56 K38 K-19 K-33 K7 000 -7 000 After tax other income/expense ————— — Net income before discontinued operations 6.68 M7.78 M12.41 M-7.24 M4.91 M 17.86 M Discontinued operations ————— — Net income 6.68 M7.78 M12.41 M-7.24 M4.91 M 17.86 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 6.68 M7.78 M12.41 M-7.24 M4.91 M 17.86 M Basic earnings per share (Basic EPS) 0.140.150.25-0.140.1 0.36 Diluted earnings per share (Diluted EPS) 0.130.160.25-0.140.1 0.37 Average basic shares outstanding 19.14 M19.14 M19.14 M19.13 M18.99 M — Diluted shares outstanding 19.14 M19.14 M19.14 M19.13 M18.99 M — EBITDA 21.25 M25.89 M30.7 M6.44 M18.91 M 81.94 M EBIT 11.61 M16.08 M20.61 M-4.06 M9.32 M 41.95 M Cost of revenue 233.2 M236.32 M239.01 M235.2 M232.01 M 942.55 M Other cost of goods sold ————— — Depreciation & amortization (cash flow) 9.65 M9.81 M10.08 M10.5 M9.59 M 39.98 M